Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2001
03/07/2001EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE
03/07/2001EP0840732B1 Substituted benzolactam compounds as substance p antagonists
03/07/2001CN1286683A Tetrahydrobenzindole derivs
03/07/2001CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system
03/07/2001CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof
03/07/2001CN1062861C Triazine derivs., production and use thereof
03/06/2001US6197975 7-azabicyclo(2.2.1)heptane-7-carbonyl-substituted 2-phenylindole derivatives; sexual disorders; anticarcinogenic agents
03/06/2001US6197958 Carboxylic acid derivatives, their preparation and use
03/06/2001US6197804 Kinase inhibitors; anticancer agents
03/06/2001US6197782 Therapy for sexual disorders
03/06/2001US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
03/06/2001CA2183655C 4-polycyclic amino-substituted quinazoline derivatives
03/01/2001WO2001014371A1 N-heterocyclic derivatives as nos inhibitors
03/01/2001WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
03/01/2001WO2001014330A2 Phenylpiperazines as serotonin reuptake inhibitors
03/01/2001WO2001014320A1 Compounds that inhibit tryptase activity
03/01/2001WO2001014288A1 Optically active isocyanurate and optical resolver comprising derivative of the same
03/01/2001WO2001013916A1 Drugs inhibiting cell death
03/01/2001WO2001000617A3 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
03/01/2001WO2000071516B1 INHIBITORS OF FACTOR Xa
03/01/2001DE19940829A1 New 3-(anilino-methylidene)-2-indolinone derivatives, are kinase inhibitors and cell proliferation inhibitors, useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
03/01/2001DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity
03/01/2001CA2381096A1 Compounds that inhibit tryptase activity
02/2001
02/28/2001EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
02/28/2001EP1077951A1 N,n'-azobis-nitroazoles and analogs thereof as igniter compounds for use in energetic compositions
02/28/2001EP1077948A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament
02/28/2001EP1077947A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
02/28/2001EP1077705A1 Potassium channel agonists
02/28/2001EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
02/28/2001EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
02/28/2001EP0888339A4 Synthesis of indolylmaleimides
02/28/2001EP0792879B1 Process for preparing 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate
02/28/2001CN1285828A Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
02/28/2001CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists
02/28/2001CN1285350A 1-cyclenes tetraazolelinketone and the like
02/28/2001CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/27/2001US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety
02/27/2001US6194447 Bis (benzimidazole) derivatives serving as potassium blocking agents
02/27/2001US6194437 Non-peptide bombesin receptor antagonists
02/27/2001US6194416 Central nervous system disorders; alzheimer's disease
02/27/2001US6194415 Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
02/27/2001US6194414 Radioprotectors
02/27/2001US6194413 Hemoregulatory compounds
02/27/2001US6194406 Histamine receptor antagonists; tachykinin receptor antagonists; asthma; bronchitis; inflammatory bowel diseases, including crohn's disease and ulcerative colitis; seasonal rhinitis; sinusitis; antiallergens; emetic agents
02/27/2001US6194396 Benzimidazole compounds as bradykinin antagonists
02/27/2001US6194132 Photographic element, compound, and process
02/27/2001CA2124206C Indole derivatives
02/22/2001WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001WO2001012612A1 Benzoic acid derivatives for the treatment of diabetes mellitus
02/22/2001WO2001012601A1 Novel anilide derivatives or salts thereof and drugs containing the same
02/22/2001WO2001012600A1 INHIBITORS OF FACTOR Xa
02/22/2001WO2001012189A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
02/22/2001WO2001012188A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
02/22/2001WO2001012186A1 Cell adhesion inhibitors
02/22/2001WO2000032588A3 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/22/2001DE19939463A1 Tryptase inhibitors useful e.g. for treating inflammatory or allergic disease, arteriosclerosis or neoplasia, comprising new or known 2-phenethyl-benzimidazole-5-carboxamides
02/22/2001CA2381975A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001CA2381090A1 Benzoic acid derivatives for the treatment of diabetes mellitus
02/22/2001CA2380817A1 Cell adhesion inhibitors
02/22/2001CA2380786A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
02/21/2001EP1077227A1 Stabilizer mixtures
02/21/2001EP1076647A2 Antipsychotic indolyl derivatives
02/21/2001CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use
02/20/2001US6191266 Sugar modified nucleosides
02/20/2001US6191161 Prolylendopeptidase inhibitors
02/20/2001US6191160 Spiro-indolines as Y5 receptor antagonists
02/20/2001US6191159 Anticoagulants
02/20/2001US6191130 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5T H1A receptors
02/20/2001US6190850 Photographic element, compound, and process
02/15/2001WO2001011370A1 Use of acylsulfonamido-substituted polymethine dyes as fluorescence dyes and/or markers
02/15/2001WO2001010864A1 1-cycloalkylpyrazoyl-benzoyl derivatives
02/15/2001WO2001010850A1 Herbicidal tetrazolinone derivatives
02/15/2001WO2001010847A2 Novel integrin receptor antagonists
02/15/2001WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
02/15/2001DE19937496A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents, e.g. for treating viral infections, tumors, inflammation or autoimmune disease
02/15/2001DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin
02/15/2001CA2381532A1 Herbicidal tetrazolinone derivatives
02/15/2001CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001CA2379977A1 Novel integrin receptor antagonists
02/14/2001EP1075467A1 Pyrazole derivatives as p-38 map kinase inhibitors
02/14/2001EP0836593B1 5-pyrazolylbenzoic acid derivatives as herbicides
02/14/2001EP0833820B1 Benzisoxazole and indazole derivatives as antipsychotic agents
02/14/2001CN1284073A 5-(2-imidazolinylamino)-benzimidazole derivatives, their prepn. and their use as alpha-adrenoceptor agonists with inproved metabolic stability
02/14/2001CN1284066A Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
02/14/2001CN1284064A 2,3-substituted indole compounds as cox-2 inhibitors
02/14/2001CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound
02/14/2001CN1283617A Terazololine-one
02/14/2001CN1283615A New Process and intermediate
02/13/2001US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate
02/13/2001US6187776 Heterocyclic compounds and their use
02/13/2001CA2203942C A pyrrolidylthiocarbapenem derivative
02/13/2001CA2001203C Novel antimicrobial dithiocarbamoyl quinolones
02/08/2001WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
02/08/2001WO2001009128A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth
02/08/2001WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors
02/08/2001WO2001009110A1 Novel succinate derivative compounds useful as cysteine protease inhibitors
02/08/2001WO2001009106A1 Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors
02/08/2001WO2001009090A2 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines